Aspira Chemical’s Pharma division (Aspira Pharma) was created in response to the growing gap between R&D speed and cost efficiency. Centered on the principle of “Collaborate Locally. Commercialize Globally.”, we provide excellence in innovation; assured, guaranteed results; attractive return-on-investments (ROIs); and ubiquitous value throughout the pharmaceutical “food chain.” Our unwavering focus and domain expertise in several core competencies generate maximum value for our clients globally in terms of innovation, IP and quality assurance, and exceptional cost efficiency. High-level segmenting of small-molecule drug and large molecule biologics services is optimally structured to define customers’ requirements by project focus. When therapeutic development can be realized at lower effective cost structures while matching clients’ timelines, favorable ROIs could be realized in virtually every program. Aspira Pharma is back integrated on two continents (North America and Asia); our subject matter scientists in the broad areas below initiate projects from the gene-to-target, translational R&D stage cascading forward to development and manufacturing stages.